|
2
|
9
|
5x8wB |
Crystal structure of the mutant human ror gamma ligand binding domain. |
|
81
|
286
|
5wciA |
Human myst histone acetyltransferase 1 |
|
41
|
116
|
5w0qA |
Crebbp bromodomain in complex with cpd17 (n,2,7-trimethyl-2,3-dihydro-4h-benzo[b][1,4]oxazine-4-carboxamide) |
|
18
|
50
|
5vjiA |
Crystal structure of the clock transcription domain exon19 in complex with a repressor |
|
43
|
114
|
5w0fA |
Crebbp bromodomain in complex with cpd3 ((s)-1-(3-(6-(1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1-(tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) |
|
38
|
114
|
5w0iA |
Crebbp bromodomain in complex with cpd8 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1-(tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) |
|
25
|
111
|
5u2jA |
Morf double phd finger (dpf) in complex with histone h3k14bu |
|
15
|
87
|
5u4kA |
Nmr structure of the complex between the kix domain of cbp and the transactivation domain 1 of p65 |
|
46
|
165
|
5trlA |
Crystal structure of human gcn5 histone acetyltransferase domain |
|
45
|
165
|
5trmA |
Crystal structure of human gcn5 histone acetyltransferase domain |
|
35
|
106
|
5tpxA |
Bromodomain from plasmodium faciparum gcn5, complexed with compound |
|
41
|
119
|
5tb6A |
Structure of bromodomain of crebbp with a pyrazolo[4,3-c]pyridin fragment |
|
3
|
12
|
5q1iB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q12B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0jB |
Ligand binding to farnesoid-x-receptor |
|
38
|
85
|
5svhA |
Crystal structure of the kix domain of cbp in complex with a mll/c-myb chimera |
|
2
|
11
|
5q1dB |
Ligand binding to farnesoid-x-receptor |
|
2
|
9
|
5q1gB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q1eB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q11B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q15B |
Ligand binding to farnesoid-x-receptor |
|
3
|
13
|
5q0xB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q18B |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q0uB |
Ligand binding to farnesoid-x-receptor |
|
3
|
10
|
5q0mB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q1hB |
Ligand binding to farnesoid-x-receptor |
|
2
|
10
|
5q16B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q1fB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q1bB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q0pB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q1cB |
Ligand binding to farnesoid-x-receptor |
|
2
|
12
|
5q0wB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q0oB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q1aB |
Ligand binding to farnesoid-x-receptor |
|
2
|
10
|
5q13B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0tB |
Ligand binding to farnesoid-x-receptor |
|
2
|
11
|
5q0zB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0yB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q0rB |
Ligand binding to farnesoid-x-receptor |
|
2
|
9
|
5q0qB |
Ligand binding to farnesoid-x-receptor |
|
2
|
11
|
5ow7B |
Vdr complex |
|
2
|
10
|
5ow9B |
Vitamin d receptor complex |
|
2
|
11
|
5owdB |
Vitamin d receptor complex |
|
38
|
114
|
5owkA |
Crystal structure of crebbp bromodomain complexed with dspb2a002 |
|
27
|
107
|
5nwxA |
Insight into the molecular recognition mechanism of the coactivator ncoa1 by stat6 |
|
43
|
119
|
5nu3A |
Crystal structure of the human bromodomain of crebbp bound to the inhibitor xdm-cbp |
|
20
|
132
|
5nwmA |
Insight into the molecular recognition mechanism of the coactivator ncoa1 by stat6 |
|
43
|
116
|
5nu5A |
Crystal structure of the human bromodomain of ep300 bound to the inhibitor xdm-cbp |
|
2
|
10
|
5nmaB |
Structure-activity relationship study of vitamin d analogs with oxolane group in their side chain |
|
38
|
115
|
5nlkA |
Crystal structure of crebbp bromodomain complexd with us13a |
